Continuing Education

Prevalence and Prognostic Significance of Frailty Among Patients With Transthyretin Amyloidosis Cardiomyopathy

May 26, 2021 Editor

Circulation: Heart Failure, Ahead of Print.

← Transitioning Clinical Care for People Who Use Drugs to Telemedicine: Lessons Learned One Year into the COVID-19 Pandemic
Exception Status Listing in the New Adult Heart Allocation System: A New Solution to an Old Problem? →